Crystallization (Comment) | Organism |
---|---|
purified recombinant mutant enzymes Q7K/L33I/L63I/C67A/C95A, V82A, and I84V in complex with inhibitor UIC-94017, hanging drop vapour diffusion method, for mutant enzyme Q7K/L33I/L63I/C67A/C95A: 2:1 or 5:1 ratios inhibitor to protein, the well solution contains 30 mM sodium acetate, pH 4.8, 10% w/v NaCl, 10% v/v glycerol, 10% v/v DMSO, and 10% dioxane at room temperature, slightly altered conditions for mutant enzymes V82A and I84V, X-ray diffraction structure determination and analysis at 1.1-1.5 A resolution, overview | Human immunodeficiency virus 1 |
Protein Variants | Comment | Organism |
---|---|---|
I84V | site-directed mutagenesis, kinetic and structural studies | Human immunodeficiency virus 1 |
Q7K/L33I/L63I/C67A/C95A | site-directed mutagenesis, mutations lead to stabilization of the enzyme for kinetic and structural studies | Human immunodeficiency virus 1 |
V82A | site-directed mutagenesis, kinetic and structural studies | Human immunodeficiency virus 1 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
UIC-94017 | TMC-114, a broad-spectrum, potent non-peptide inhibitor of HIV-1 protease, the inhibitor shows low cytotoxicity, enzyme binding structure analysis | Human immunodeficiency virus 1 |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.044 | - |
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide | pH 5.0, mutant V82A | Human immunodeficiency virus 1 | |
0.055 | - |
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide | pH 5.0, mutant Q7K/L33I/L63I/C67A/C95A | Human immunodeficiency virus 1 | |
0.211 | - |
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide | pH 5.0, mutant I84V | Human immunodeficiency virus 1 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 1 | - |
i.e. HIV-1 | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide + H2O | the peptide substrate mimicks the CA-p2 cleavage site | Human immunodeficiency virus 1 | Lys-Ala-Arg-Val-Nle + 4-nitro-Phe-Glu-Ala-Nle-amide | - |
? |
Synonyms | Comment | Organism |
---|---|---|
HIV-1 protease | - |
Human immunodeficiency virus 1 |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
194.5 | - |
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide | pH 5.0, mutant V82A | Human immunodeficiency virus 1 | |
285 | - |
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide | pH 5.0, mutant Q7K/L33I/L63I/C67A/C95A | Human immunodeficiency virus 1 | |
780 | - |
Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide | pH 5.0, mutant I84V | Human immunodeficiency virus 1 |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
5 | - |
assay at | Human immunodeficiency virus 1 |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000001 | - |
UIC-94017 | pH 5.0, mutant Q7K/L33I/L63I/C67A/C95A | Human immunodeficiency virus 1 | |
0.0000013 | - |
UIC-94017 | pH 5.0, mutant V82A | Human immunodeficiency virus 1 | |
0.0000032 | - |
UIC-94017 | pH 5.0, mutant I84V | Human immunodeficiency virus 1 |